Kopin ($KOPN): Revenue Up 51% as MicroLED and Sentinel Hit Milestones

03 The latest filings, and what they change

Kopin’s second quarter closed on June 27, 2026 and was reported on August 10, with the Form 10-Q following on August 11. Two things arrived after the quarter that management puts in the same release: three color MicroLED milestones under the U.S. government’s Industrial Base Analysis and Sustainment initiative, and multiple Sentinel FPV prototype orders from customers competing in the Drone Dominance Program.

Earlier in the year, on May 28, Theon exercised its conversion right and turned all 1,000 outstanding Series A convertible preferred shares into common stock at $3.00 a share, which simplifies the capital structure and changes the share count. The annual report was filed on April 13. Those three documents, plus the litigation note in the Form 10-Q, are what this page rests on.

04 The company, and what it sells

Kopin Corporation designs and makes application-specific optical systems and microdisplays, in Westborough, Massachusetts, and sells them into defence, AI infrastructure, enterprise, industrial and medical products. The portfolio runs from microdisplays and display modules to eyepiece and projection assemblies and head-mounted systems, built on liquid crystal, MicroLED and OLED technologies, with optics and low-power custom silicon alongside.

The company is small, and the filings are candid about the shape of it: product revenue was $7.6 million in the quarter, and the rest of the $12.7 million came from grants, collaboration agreements, licences and royalties. That split matters more than the growth rate, because it says how much of the business is selling things and how much is being funded to develop them.

Michael Murray is chief executive officer and Erich Manz is chief financial officer. The company has generated revenue from defence programmes for years while carrying losses, and management’s stated aim is progress toward sustainable GAAP profitability in the fourth quarter of 2026.

05 Defence: where the product revenue comes from

Defence is almost the whole of Kopin’s product revenue. In the second quarter, defence revenue was $7,310,425 against $6,222,034 a year earlier, while industrial revenue fell to $20,400 from $1,030,977. Over the half, defence was $12,620,828 and industrial $67,718.

That concentration is a choice as much as a market: the company has moved toward the programmes where the demand is funded and the qualifications are hard to get, and away from the industrial and consumer work that used to fill the order book. It also means the revenue line now moves with a handful of defence programmes rather than with a broad customer base.

The applications named in the filings are thermal weapon sights, liquid crystal displays for defence use, and the display elements that go into helmet and vehicle-mounted systems. Higher defence revenue from thermal weapon sight applications and liquid crystal displays was what offset the fall in industrial work, in the company’s own account of the quarter.

06 MicroLED: three milestones and a date

The colour MicroLED programme is funded by the U.S. government under the Industrial Base Analysis and Sustainment initiative, and it is the part of the story where the company has measurable progress rather than intentions. Three milestones were delivered after the quarter: more than 150,000 nits of single-panel full-colour brightness, which the company says exceeds the programme’s threshold target; early integration progress toward U.S. Army ground soldier vision systems, supporting programmes such as Soldier Borne Mission Command; and the delivery of new U.S. MicroLED bonding equipment at the Westborough headquarters.

The company states the consequence it draws from those: it remains on track for domestic MicroLED production in mid-2027. That is a date to hold loosely and to check against the filings as they come, because it is the company’s own forward-looking statement and not a result; what is filed is the milestone and the equipment delivery.

Brightness matters because colour microdisplays for soldier-worn systems have to be readable in daylight. The threshold in the programme is the number the customer set, and exceeding it is the kind of fact that shows up in the next phase of a funded programme rather than in a headline.

07 Sentinel FPV: from prototype to volume

Sentinel FPV is Kopin’s entry into first-person-view drones, and the quarter’s subsequent events are the first evidence that it is converting. The company reported multiple new prototype orders from customers evaluating Sentinel as a core part of their offerings for the U.S. government’s one-way attack drone initiative, including several active contenders in the Drone Dominance Program.

The timeline the company gives is specific: volume orders expected to begin in late August 2026, immediately after the programme’s Phase 2 evaluations and awards. That makes the programme’s outcome, not Kopin’s own progress, the thing that decides whether the drone work becomes revenue. Management also says it is negotiating several large production orders for 2027 and that it sees demand from drone customers both inside and outside the Drone Dominance Program.

The distinction to keep: a prototype order is revenue, and a position with a contender is not revenue until the contender wins and orders. The company describes the Dual Situational Awareness design as the differentiator, and argues that demand for trusted, U.S.-built FPV technology is what drives it.

08 Neural I/o: the AI interconnect, and its date

Neural I/o is the company’s bid to sell optical interconnects into AI data centres, built on the idea of using programmable MicroLED pixels as ultra-high-speed, low-power optical transceivers. The work with Fabric.AI advanced in the quarter with several new non-disclosure agreements, including some with current NVIDIA NVLink partners, and the first of a planned series of AI interconnect white papers.

The company says it expects to demonstrate the platform at CES in January 2027, with a path to production anchored by a 1.6-terabit-per-second transceiver. It also opened an Optics and Photonics Design Center in Dallas, Texas, to work on it.

This is the part of the story with the least filed substance behind it. A non-disclosure agreement is a permission to talk, not a customer; a white paper is a document, not a product; and a demonstration date is a plan. What the filings do support is that the company is spending on it and that collaboration revenue is arriving from it, which is why it appears on the income statement at all.

09 Theon, and the preferred shares that went away

Kopin carried a series of Series A convertible preferred stock, and on May 28, 2026 Theon exercised its conversion right under the certificate of designation, converting all 1,000 outstanding shares into common stock at a conversion price of $3.00 a share. After the conversion no Series A convertible preferred stock was issued or outstanding as of June 27, 2026.

A conversion is not a capital raise and not a repayment. It moves a claim from one line of the capital structure to another: where the company had preferred shares with a liquidation preference, it now has more common stock outstanding and one less structural claim ahead of the ordinary shareholder. The stated $3.00 conversion price is also a dated reference point, about a third below the reference price of the September 18 close used elsewhere in this page.

The reason the transaction is worth a section is that it changes the share count: the count that matters for dilution is the one on the cover page of the most recent filing, and this is why it moved during the year.

There is a second, larger Theon transaction underneath the conversion. On August 8, 2025 the company announced strategic agreements for an aggregate $15 million strategic investment from Theon International Plc, and the agreements closed on October 16, 2025. Theon acquired a 49% interest in Kopin Europe Ltd., the parties signed a licensing and collaboration agreement covering joint development of military products including the DarkWave module and subsystem and certain MicroLED and OLED displays, and Theon bought shares and a note. On the same date, the substantive participating rights given to Theon meant the company lost its controlling financial interest in Kopin Europe, and the subsidiary was deconsolidated; its assets, liabilities and operations left the consolidated accounts, and the remaining equity interest is carried under the equity method with the fair value option.

That is a comparability fact, not a footnote: revenue and costs from Kopin Europe stop appearing in the consolidated lines from the October 2025 deconsolidation onward, and Theon is a related party.

10 The quarter in numbers

Total revenues were $12.7 million against $8.5 million a year earlier, an increase of 51%. The composition is the interesting part. Product revenues were $7.6 million against $7.5 million, an increase of 2%. Non-product revenues were $5.1 million against $1.0 million, an increase of 433%, made up of funded research and development, collaboration agreements, grants, licence and royalty revenue.

Cost of product revenues was $6.6 million, 86% of net product revenues, against $7.1 million and 94% a year earlier, which the company attributes to product mix. Research and development rose to $4.5 million from $1.9 million, driven by the funded costs of the MicroLED government award, and selling, general and administrative expenses rose to $5.1 million from $4.9 million.

The result: a loss from operations of $3.5 million, against $5.5 million a year earlier. Net income attributable to common stockholders was $0.9 million, or $0.00 a share, against a net loss of $5.2 million a year earlier. The swing is not the operating improvement: the company attributes it to higher total revenues, a $1.9 million increase in other income largely from about $2.3 million of gains on investments, and a $2.1 million income tax benefit from the expiration of the statute of limitations on an uncertain tax position.

11 Where the revenue comes from, and why the split matters

The chart below shows the quarter split between product revenue and non-product revenue, and it is the single most useful picture of this company. Product revenue is what Kopin sells; non-product revenue is what Kopin is paid to develop, through funded research and development, collaboration agreements, grants, licences and royalties.

The company’s own explanation of the 51% increase names grant revenue under the MicroLED award, collaboration revenue from the Fabric.AI development programme and the AR/thermal clip-on partnership, and higher research and development revenue on the Phase 2 Off-the-Visor Heads-Up Display programme with the U.S. Army. Every one of those is non-product.

That is not a criticism of the revenue, which is real and paid. It is a statement about what the revenue measures: a company that is being funded to develop, more than a company that is selling what it has developed. The transition happens if and when the mid-2027 production date and the drone volume orders turn into product revenue.

12 The balance sheet, and the cash the company cannot use

At June 27, 2026 total assets were $106,259,963 against $108,394,257 at December 27, 2025. Total liabilities were $37,048,744 and total stockholders’ equity $69,211,219, against $36,720,613 and $64,117,163. Current assets were $79,286,270.

Cash and cash equivalents were $24,876,516, down from $36,350,083 at the start of the year. But the figure that matters is the one the company spells out in the release: total cash, restricted cash and marketable securities of $50.3 million, inclusive of $26.0 million of restricted cash, of which $24.2 million collateralises the supersedeas bond posted in connection with the BlueRadios litigation appeal.

So the unrestricted cash the company can spend is $24.88 million, and the money held against a judgment on appeal — $24.2 million — is nearly all of it. The liquidity note states the financial statements are prepared on a going concern basis and that the company incurred a net loss of $2.9 million and net cash outflows from operations of $5.1 million in the six months to June 27, 2026, partly from funding its investment in research and development.

13 BlueRadios: a judgment on appeal

The litigation is old and specific. On August 12, 2016 BlueRadios sued Kopin in the U.S. District Court for the District of Colorado, alleging breach of a contract concerning the design, development and commercialisation of microdisplay products with embedded wireless technology referred to as “Golden-i”, breach of the covenant of good faith and fair dealing, breach of fiduciary duty and misappropriation of trade secrets owned by BlueRadios under Colorado law. As of December 28, 2024 the company had accrued $24.7 million related to a jury verdict, a figure the same Form 10-Q also states as $24.8 million in its critical accounting discussion; the two do not reconcile and the discrepancy is the company’s.

On September 5, 2025 a post-trial order for $19.7 million was awarded, and the company reduced the accrual to $19.7 million, recognising a benefit of $5.1 million in the 2025 statements. On October 2, 2025 the company posted a supersedeas bond for $23.0 million — the judgment plus legal expenses and interest over the expected term of the appeal — by depositing $24.2 million in the bank, which issued a letter of credit to a surety company that issued the bond to the court.

The company has appealed the verdict, and BlueRadios has filed its opening and response appellate brief in the Federal Circuit, asking the court to affirm the September 2025 judgment for trade secret misappropriation and to reverse the parts of the district court decision that denied additional damages, injunctive relief and unpaid retainer claims. The bond exists because the judgment is enforceable while the appeal runs: if the appeal fails, the money is already where the court can take it. That is why a $19.7 million accrual sits on the balance sheet of a company with $24.88 million of unrestricted cash, and why the note states that the bond is available to satisfy payment of the judgment.

14 Shares, and what has changed in the count

The cover page of the Form 10-Q filed on August 11, 2026 reports 185,872,614 shares of common stock outstanding as of August 11, 2026. That is the freshest count the company declares, and it is the one used for the market capitalisation above, with the September 18, 2026 close.

Two things moved the count during the year. The Theon conversion on May 28 turned 1,000 Series A convertible preferred shares into common stock at $3.00, removing the preferred class and adding to the common. And the company filed a registration statement on Form S-8 on August 12, 2026, which registers shares for issuance under an equity plan: registration is capacity to issue, not issuance, and it is the kind of filing that tells a reader where future dilution can come from.

For a company at this market capitalisation the share count is the variable that decides whether progress per share survives progress in the business, and the two mechanisms above are the ones the filings describe.

15 Market: what the fields say, and what they do not

The market fields quoted below come from a provider aggregate read on September 20, 2026, and the date beside each figure is the date it belongs to. They are not figures the company files, and they change with the provider’s own reporting lags.

The reading that stands out is short interest at 15.35% of the float against 185.87 million shares outstanding. A short reading of that size on a small-capitalisation company with a judgment on appeal and a negative operating line is not a verdict in itself: it can express doubt about the funding position, a view on the technology timelines, or simply positioning around an event.

What the fields cannot be used for is the arithmetic of the business. No figure from them enters the calculations below, and the market capitalisation is a Merlintrader calculation from two dated inputs the company does declare: the cover-page share count and the September 18 close.

16 Sentiment, and how to read it

Kopin is a heavily discussed small-capitalisation stock, and the discussion around it mixes the technology story with the balance-sheet story, which is exactly the mix the filings themselves present. The comments are those of retail traders and non-professional investors, not analysts, and a reading that looks one-sided on a name like this is a signal to check a filing rather than a conclusion about the company.

The two things a reader should look for in the discussion, and verify elsewhere, are the dates: whether the drone volume orders the company expects after the Phase 2 evaluations have actually been announced, and whether anything has happened in the appeal. Both are filed events, and both would change the picture more than any sentiment reading.

17 Catalysts to watch

The third quarter has no announced date in the documents reviewed. When it arrives, four lines decide the reading: product revenue against the $7.6 million of this quarter, the operating loss without the help of investment gains, the cash balance and the restricted cash note, and any disclosure on the appeal.

Besides the quarterly report, three filed events would matter. The first is the drone volume orders the company says it expects from late August, after the Drone Dominance Program’s Phase 2 evaluations and awards. The second is the mid-2027 domestic MicroLED production date, which is a company statement to be tested against each filing. The third is CES in January 2027, where management says it will demonstrate Neural I/o.

18 Risks, and what would make them worse

The judgment. A $19.7 million accrual on appeal, collateralised with $24.2 million of restricted cash, in a company with $24.88 million of unrestricted cash. If the appeal fails the money is already pledged; if the appeal succeeds the restriction should lift. It is the largest quantity on this balance sheet that is not a matter of operating performance.

The operating line. A loss from operations of $3.5 million in the quarter and net cash outflows from operations of $5.1 million in the half, with the liquidity note stating the accounts are prepared on a going concern basis. The company’s answer is the funded programmes and the guidance for the second half; the evidence will be the next two quarterly cash-flow statements.

The composition of growth. Product revenue grew 2% while total revenue grew 51%. A company whose growth is grant and collaboration revenue is a company whose growth depends on programmes continuing to be funded, and the transition to product revenue depends on the MicroLED and drone timelines.

Concentration and timelines. Defence is almost all of product revenue, and the dates that matter — mid-2027 for MicroLED production, late August for drone volume, January 2027 for CES — are the company’s own. Also in the file: the $2.1 million tax benefit and $2.3 million of investment gains that turned an operating loss into reported net income, and 15.35% short interest against the float.

19 Merlintrader bottom line

Kopin’s second quarter is a company making technical progress and selling a little more of what it makes. Revenue of $12.7 million was 51% above the year before, but product revenue — the part that is selling rather than being funded to develop — grew 2%, and the growth came from grants, collaboration revenue and funded research and development. The operating loss narrowed to $3.5 million from $5.5 million, and the net income of $0.9 million came from a $2.3 million gain on investments and a $2.1 million tax benefit rather than from the operating line.

The balance sheet is the part to read twice. Unrestricted cash is $24.88 million, down from $36.35 million at the start of the year, and $24.2 million more is deposited with a bank as collateral for a $23.0 million supersedeas bond posted against a $19.7 million judgment now on appeal. The liquidity note says the accounts are prepared on a going concern basis.

The things that would change this are all dated and filed: the drone volume orders expected after the Drone Dominance Program’s Phase 2 awards, domestic MicroLED production in mid-2027, and whatever the appeal decides. Until product revenue grows faster than non-product revenue, the company is being paid to develop more than it is being paid to deliver, and the headlines about milestones are milestones, not revenue. This is not a recommendation and not a prediction; it is where the documents reviewed on September 21, 2026 leave the question.

Related Research On Merlintrader

• Space, Defense & AI Stock Hubs — the sector index
• Free Catalyst Calendar